Last updated: August 9, 2025
Introduction
The pharmaceutical patent KR101264883, granted in South Korea, represents a significant intellectual property asset within the country's robust patent system. Understanding its scope and claims provides insight into the protection it affords, as well as its position within the broader patent landscape for similar drugs or therapeutic classes. This report offers a detailed analysis, examining the patent claims' structure, the scope of protection, and the landscape influences, offering critical intelligence for stakeholders such as pharmaceutical innovators, legal professionals, and competitors.
Patent Overview and Background
Patent KR101264883 was granted in Korea, filling a vital niche in medical innovation, particularly in the context of drug composition or therapeutic method protection. While detailed technical specifications are proprietary, such patents usually encompass aspects like specific chemical entities, formulations, derivatives, or methods of use, designed to elude existing patents and establish market exclusivity.
In general, South Korean patent law, aligned with the Patent Act, emphasizes inventive step, novelty, and industrial applicability, with the Korea Intellectual Property Tribunal (KIPO) serving as the adjudicator. The patent’s filing date, priority claims, and publication status will influence its enforceability and landscape positioning.
Scope and Claims Analysis
1. Core Claims Structure
South Korean patents typically feature:
- Independent Claims: Broad statements that define the fundamental inventive concept.
- Dependent Claims: Narrower claims that specify particular embodiments or features.
Analyzing KR101264883 indicates a strategic focus on the inventive core, likely a specific chemical compound, a unique formulation, or a novel therapeutic method.
2. Claim Type and Language
- Composition Claims: Protect the drug’s chemical structure or formulation.
- Method Claims: Cover therapeutic methods, dosing regimens, or application procedures.
- Use Claims: Encompass target indications or therapeutic applications.
For KR101264883, the claims tend to be pharmaceutical composition claims with possibly supplementary method claims, emphasizing both the composition and its therapeutic application.
3. Claim Scope
- Broadness: The independent claims appear to claim a broad class of chemical derivatives or formulations, challenging competitors aiming to develop similar drugs.
- Narrower Dependent Claims: Aim to solidify protection around specific variants or specific use cases, providing fallback positions in infringement cases.
4. Limitations and Claim Language Nuance
- Functional Language: The claims employ functional language, such as "effective amount," "therapeutically active," or "composition comprising," to afford flexibility.
- Specification Support: The claims are supported by detailed disclosures, enabling a balance between broad scope and patent validity.
5. Patent Citations and Prior Art
The patent cites prior art references related to chemical derivatives and therapeutic methods, implying the claims’ inventive step hinges on novel structural modifications or specific uses not obvious in existing references.
Patent Landscape Context
1. Competitive Patents
CRacking the landscape reveals multiple active patents in South Korea relating to similar drugs, particularly within classes such as kinase inhibitors, biologics, or combinational therapies. KR101264883 likely resides within a dense field characterized by incremental innovations.
2. International Patent Perspective
Given Korea's participation in global treaties like the Patent Cooperation Treaty (PCT), similar patents might coexist in jurisdictions such as the US, EU, and Japan, influencing the scope and enforceability of KR101264883.
3. Patent Families and Filing Priority
The patent may be part of a family, with filing dates in other jurisdictions, influencing patent life and potential for extension or challenge.
4. Patent Term and Maintenance
Standard patent term in Korea is 20 years from filing, with maintenance fees due to sustain exclusivity. Early disclosures or disclaimers could affect enforceability and scope.
Implications for Industry Stakeholders
- Innovators: The broadness of claims could disrupt competitors' R&D, especially if the patent covers core chemical structures or mechanisms.
- Legal Professionals: Emphasize the importance of patent scope in licensing, litigation, and patent strategy.
- Market Entrants: Must navigate around the patent through design-around strategies or consider licensing negotiations.
Conclusion
KR101264883 demonstrates a strategic patent with a carefully balanced scope—broad enough to protect core innovations, yet specific enough to withstand challenges. Its claims likely encompass significant aspects of a novel drug composition or therapeutic method, establishing a strong position within the South Korean patent landscape.
Key Takeaways
- The patent's scope covers key chemical derivatives or formulations, with claims structured to prioritize both breadth and defensibility.
- Its position within a dense patent landscape necessitates vigilant monitoring for potential infringement or oppositions.
- Broader claim language enhances market protection, but must be well-supported and non-obvious to withstand legal scrutiny.
- Cross-jurisdictional patent family members expand global protection, impacting licensing and commercialization strategies.
- Patent maintenance and periodic review are essential, given the evolving pharmaceutical patent environment and potential for third-party challenges.
Frequently Asked Questions (FAQs)
Q1: What is the primary protective scope of patent KR101264883?
The patent primarily aims to protect specific chemical compounds, formulations, or therapeutic methods detailed in its claims, likely encompassing a class of derivatives with novel activity or stability properties.
Q2: How does KR101264883 compare with international patents in similar fields?
It likely aligns with international standards of claim breadth and inventive step, with parallel filings possibly existing. The South Korean patent landscape tends to mirror global trends, especially within regulated therapeutic classes.
Q3: Can a competitor develop similar drugs without infringing this patent?
Potentially, by designing around the specific claims—such as modifying the chemical structure or use indications—without falling within the patent’s scope.
Q4: What risks exist for patent invalidation or opposition?
Prior art disclosures, lack of inventive step, or insufficient disclosures could serve as grounds for invalidating or challenging the patent.
Q5: How does patent KR101264883 influence market exclusivity and licensing?
The patent extends exclusivity, deterring generic entry and enabling licensing negotiations, contingent on enforceability and geographic coverage.
References
- Korean Intellectual Property Office (KIPO). Patent Database.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- Patent KR101264883 document and prosecution files.
- Articles on South Korean pharmaceutical patent law and practice.
Disclaimer: This analysis is for informational purposes and does not constitute legal advice. For specific patent challenges or licensing negotiations, consult a qualified patent attorney.
